Both describe PUVA. Choose 96913 when the severe-dermatosis regimen requires at least four to five treatments weekly for six to eight weeks; 96912 describes PUVA without that intensive schedule.
On this page
CMS RVU26D · Effective 2026-10-01
96913 PUVA therapy Medicare reimbursement rates in Oregon
Report this code for psoralen-UVA photochemotherapy prescribed for severe dermatoses on an intensive schedule of at least four to five treatments weekly for six to eight weeks. Compare 96913 office and facility rates across CMS payment localities in Oregon.
Amounts below use the non-QP conversion factor for participating physicians. These are base physician payments before claim-level adjustments, not patient costs or total hospital charges.
What does Medicare pay for 96913 in Oregon?
Oregon has 2 payment localities in this comparison. Use the service location to choose the applicable amount. These are the supported base rates for the 2 payment areas shown below, using the same CMS release.
Office / nonfacility
$146.42–$163.28
2 of 2 localities have a supported rate.
Facility setting
No supported rate
These are locality ranges, not averages or address-specific quotes. A facility-setting amount covers the physician service; it does not include a hospital’s separate bill. Choose a locality below to inspect its calculation, compare other payment areas, or price a percentage of Medicare.
Dermatology treatment
About 96913: Intensive PUVA photochemotherapy
Report this code for psoralen-UVA photochemotherapy prescribed for severe dermatoses on an intensive schedule of at least four to five treatments weekly for six to eight weeks.
This service is PUVA photochemotherapy: psoralen is administered as part of treatment, followed by controlled exposure to ultraviolet A light. Dermatologists commonly use it for severe dermatoses, including severe psoriasis, when the treatment plan calls for an intensive course. The service is provided in a dermatology or phototherapy setting by the treating clinician or trained staff operating under the required supervision.
Select this code when the documented PUVA plan meets the intensive schedule specified for severe dermatoses: at least four to five treatments per week for six to eight weeks. The record should support the diagnosis, use of psoralen and UVA, and prescribed treatment frequency and course. The code distinguishes this intensive regimen from the PUVA service reported with 96912. CMS identifies it as an incident-to service; when billed incident-to, it must be performed under physician supervision.
CMS billing rules for 96913
- Professional and technical components
- Incident-to service: billed only when performed under physician supervision.
Where the value comes from
- Work RVU0.00 · 0%
- Practice expense (office) RVU4.38 · 99%
- Malpractice RVU0.03 · 1%
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
96913 compared with similar codes
Office rates for Oregon, from the same CMS release.
96910 describes photochemotherapy using tar or petrolatum with UVB. 96913 is for psoralen combined with UVA.
96900 is ultraviolet light treatment without the psoralen component of PUVA; 96913 describes psoralen-UVA photochemotherapy for severe dermatoses on an intensive schedule.
Compare 96913 by payment locality
Find the payment area for your service address, then open its rate page for calculation inputs, release history and the percentage-of-Medicare tool. A city may cross payment-area boundaries; the ZIP lookup above helps resolve the location.
2 of 2 payment localities
Portland →
Office / nonfacility
$163.28
Facility
Unavailable
Rest Of Oregon →
Office / nonfacility
$146.42
Facility
Unavailable
Need rates for a whole code list?
Fee-sheet and API access are in early access. Tell us which codes and locations your team needs.
96913 billing questions
When should 96913 be chosen instead of 96912?
Use 96913 for PUVA treatment of severe dermatoses when the prescribed course requires at least four to five treatments weekly for six to eight weeks. Use 96912 for PUVA when that intensive schedule is not documented.
Does this service include both psoralen and UVA treatment?
Yes. The photochemotherapy service includes psoralen administration and UVA exposure; document both as part of the treatment.
What documentation supports reporting 96913?
Document the severe dermatosis, the PUVA treatment, and the prescribed frequency and course supporting the intensive schedule.
Can staff provide the service for incident-to billing?
CMS permits incident-to billing only when the service is performed under physician supervision.
Is 96913 appropriate for UVB treatment?
No. This code describes psoralen-UVA photochemotherapy. Tar or petrolatum with UVB is described by 96910.
Where these rates come from
FeeBase calculates base physician payments from CMS work, practice-expense, and malpractice RVUs, adjusted by each locality’s geographic indices and the applicable conversion factor. Unavailable or separately priced services are labeled rather than assigned a made-up amount.
Source: RVU26D. Effective 2026-10-01 through the day before 2027-01-01.
